These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 215106)
1. Antigenic content of an in vitro cellular immunity reactive cell surface extract of Raji cells. Ng MH; Ng WS; Ho HC Arch Virol; 1978; 58(3):213-20. PubMed ID: 215106 [TBL] [Abstract][Full Text] [Related]
2. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody. Szigeti R; Sulitzeanu D; Henle G; Henle W; Klein G Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4178-82. PubMed ID: 6330746 [TBL] [Abstract][Full Text] [Related]
3. A study of Epstein Barr virus receptor activity in cell free extracts of human lymphoblastoid cells. Ng MH; Lui SW; Chan KH Arch Virol; 1978; 58(3):221-33. PubMed ID: 215107 [TBL] [Abstract][Full Text] [Related]
4. Expression of the BLA antigen, defined by the monoclonal 38.13 antibody, on Burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other B-cell lymphomas and leukemias. Klein G; Manneborg-Sandlund A; Ehlin-Henriksson B; Godal T; Wiels J; Tursz T Int J Cancer; 1983 May; 31(5):535-42. PubMed ID: 6303966 [TBL] [Abstract][Full Text] [Related]
5. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus. Fresen KO; zur Hausen H Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313 [TBL] [Abstract][Full Text] [Related]
6. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos). Takimoto T; Sato H; Ogura H Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055 [TBL] [Abstract][Full Text] [Related]
7. Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA. Clements GB; Klein G; Povey S Int J Cancer; 1975 Jul; 16(1):125-33. PubMed ID: 170210 [TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of cell-mediated immunity to Epstein-Barr herpesvirus by cell migration inhibition tests. Lai PK; Alpers MP; Mackay Scollay EM J Natl Cancer Inst; 1975 Dec; 55(6):1319-22. PubMed ID: 173867 [TBL] [Abstract][Full Text] [Related]
9. Analysis of transformation with Epstein-Barr virus and phenotypic characteristics of lymphoblastoid cell lines established from patients with hairy cell leukemia. Sairenji T; Spiro RC; Reisert PS; Paquin L; Sakamoto K; Shibuya A; Sullivan JL; Katayama I; Humphreys RE Am J Hematol; 1983 Dec; 15(4):361-74. PubMed ID: 6316777 [TBL] [Abstract][Full Text] [Related]
10. Infection and persistence of varicella-zoster virus in lymphoblastoid Raji cell line. Leventon-Kriss S; Gotlieb-Stematsky T; Vonsover A; Smetana Z Med Microbiol Immunol; 1979; 167(4):275-83. PubMed ID: 232537 [TBL] [Abstract][Full Text] [Related]
11. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. Gregory CD; Rowe M; Rickinson AB J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133 [TBL] [Abstract][Full Text] [Related]
12. Immunofluorescence and anti-complement immunofluorescence absorption tests for quantitation of Epstein-Barr virus-associated antigens. Reedman BM; Hilgers J; Hilgers F; Klein G Int J Cancer; 1975 Apr; 15(4):566-71. PubMed ID: 166941 [TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of Epstein-Barr virus gp350-expressing transfected human lymphoid (Raji) cell clones. Khyatti M; Patel PC; Menezes J Int J Cancer; 1991 Jun; 48(4):591-7. PubMed ID: 1646179 [TBL] [Abstract][Full Text] [Related]
14. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to Epstein-Barr virus. Klein G; Falk L; Falk K Intervirology; 1978; 10(3):153-64. PubMed ID: 210135 [TBL] [Abstract][Full Text] [Related]
15. Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV. Fresen KO; Cho MS; zur Hausen H Int J Cancer; 1978 Oct; 22(4):378-83. PubMed ID: 212377 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells. Qualtiere LF; Pearson GR Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099 [TBL] [Abstract][Full Text] [Related]
17. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031 [TBL] [Abstract][Full Text] [Related]
18. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen. Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635 [TBL] [Abstract][Full Text] [Related]
19. A novel surface antigen on lymphoid cells transformed by Epstein-Barr virus. Hinuma Y; Sakamoto K IARC Sci Publ (1971); 1978; (24 Pt 1):249-51. PubMed ID: 87368 [TBL] [Abstract][Full Text] [Related]
20. SV40-transformed cells express SV40 T antigen-related antigens on the cell surface. Henning R; Lange-Mutschler J; Deppert W Virology; 1981 Jan; 108(2):325-37. PubMed ID: 6258291 [No Abstract] [Full Text] [Related] [Next] [New Search]